Capital Advisors, Ltd. LLC Amphastar Pharmaceuticals, Inc. Transaction History
Capital Advisors, Ltd. LLC
- $793 Million
- Q4 2024
A detailed history of Capital Advisors, Ltd. LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 90 shares of AMPH stock, worth $2,462. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90
Previous 99
9.09%
Holding current value
$2,462
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$163 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$74.3 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$50.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$43.7 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$37.6 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.34B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...